These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 15307518

  • 21. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE, Monasterolo G, Coco G, Silvestro L, Operti D.
    Vaccine; 2007 Jan 15; 25(5):957-64. PubMed ID: 17045368
    [Abstract] [Full Text] [Related]

  • 22. An observational study on outgrowing food allergy during non-birch pollen-specific, subcutaneous immunotherapy.
    Alonso R, Enrique E, Pineda F, Basagaña M, San Miguel-Moncín MM, Bartra J, Palacios R, Cisteró-Bahíma A.
    Int Arch Allergy Immunol; 2007 Jan 15; 143(3):185-9. PubMed ID: 17284927
    [Abstract] [Full Text] [Related]

  • 23. The early effect of specific immunotherapy on lymphocyte response to PHA and allergens in atopic patients with allergic rhinitis.
    Kinikli G, Tülek N, Sentürk T, Turgay M, Tutkak H, Duman M, Tokgöz G.
    Allergol Immunopathol (Madr); 1996 Jan 15; 24(2):65-9. PubMed ID: 8933891
    [Abstract] [Full Text] [Related]

  • 24. Safety and efficacy of specific immunotherapy with standardized allergenic extracts adsorbed on aluminium hydroxide.
    Wüthrich B, Gumowski PL, Fäh J, Hürlimann A, Deluze C, André C, Fadel R, Carat F.
    J Investig Allergol Clin Immunol; 2001 Jan 15; 11(3):149-56. PubMed ID: 11831445
    [Abstract] [Full Text] [Related]

  • 25. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
    Pipet A, Botturi K, Pinot D, Vervloet D, Magnan A.
    Respir Med; 2009 Jun 15; 103(6):800-12. PubMed ID: 19216064
    [Abstract] [Full Text] [Related]

  • 26. [Cluster-immunotherapy in seasonal allergic rhinitis: safety aspects of induction therapy with depot allergoids (Purethal)].
    Hansen I, Hörmann K, Stuck BA, Schneider-Gêne S, Mösges R, Klimek L.
    Laryngorhinootologie; 2003 Aug 15; 82(8):558-63. PubMed ID: 12915987
    [Abstract] [Full Text] [Related]

  • 27. Pollen-specific rush immunotherapy: clinical efficacy and effects on antibody concentrations.
    Movérare R, Vesterinen E, Metso T, Sorva R, Elfman L, Haahtela T.
    Ann Allergy Asthma Immunol; 2001 Mar 15; 86(3):337-42. PubMed ID: 11289336
    [Abstract] [Full Text] [Related]

  • 28. Enhancement of the frequency and function of IL-10-secreting type I T regulatory cells after 1 year of cluster allergen-specific immunotherapy.
    Lou W, Wang C, Wang Y, Han D, Zhang L.
    Int Arch Allergy Immunol; 2012 Mar 15; 159(4):391-8. PubMed ID: 22846686
    [Abstract] [Full Text] [Related]

  • 29. [The effect of specific immunotherapy on serum eotaxin level in patients with pollinosis: preliminary studies].
    Jahnz-Rózyk K, Głodzińska-Wyszogrodzka E, Rozyńska-Polańska R, Paluchowska E, Zabielski LS.
    Pol Merkur Lekarski; 2001 Sep 15; 11(63):244-6. PubMed ID: 11761820
    [Abstract] [Full Text] [Related]

  • 30. Long-term immunotherapy for perennial allergic rhinitis: relationship of specific IgG levels to skin-prick test results and clinical symptoms and signs.
    Tahamiler R, Canakcioglu S, Yilmaz S, Isildak H.
    Ear Nose Throat J; 2008 Dec 15; 87(12):E29. PubMed ID: 19105132
    [Abstract] [Full Text] [Related]

  • 31. Long-term allergen-specific immunotherapy correlates with long-term allergen-specific immunological tolerance.
    Ali I, Goksal K, Ozan B, Gulsen D.
    Adv Ther; 2008 Jan 15; 25(1):29-36. PubMed ID: 18224290
    [Abstract] [Full Text] [Related]

  • 32. [Therapy of allergic rhinitis].
    Rasp G.
    Laryngorhinootologie; 1993 Aug 15; 72(8):373-8. PubMed ID: 8104404
    [Abstract] [Full Text] [Related]

  • 33. Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus.
    Piazza I, Bizzaro N.
    Ann Allergy; 1993 Nov 15; 71(5):461-9. PubMed ID: 7755664
    [Abstract] [Full Text] [Related]

  • 34. [The results of extra diagnostic methods in patients allergic to dust mites treated by specific immunotherapy].
    Modrzyński M, Mazurek H, Zawisza E.
    Przegl Lek; 2005 Nov 15; 62(12):1337-42. PubMed ID: 16786743
    [Abstract] [Full Text] [Related]

  • 35. [Immunotherapy is effective in the treatment of allergic rhinitis. Retrospective study of 67 cases].
    Bleda C, Soler R, Romaguera A, Mas S, Juan JM.
    Acta Otorrinolaringol Esp; 1998 Nov 15; 49(5):369-72. PubMed ID: 9717325
    [Abstract] [Full Text] [Related]

  • 36. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.
    Ferreira MB, Santos AS, Santos MC, Carlos ML, Barbosa MA, Carlos AG.
    Eur Ann Allergy Clin Immunol; 2005 Mar 15; 37(3):96-102. PubMed ID: 15918296
    [Abstract] [Full Text] [Related]

  • 37. The effect of specific immunotherapy on the expression of costimulatory molecules in late phase reaction of the skin in allergic patients.
    Plewako H, Arvidsson M, Oancea I, Hasséus B, Dahlgren U, Rak S.
    Clin Exp Allergy; 2004 Dec 15; 34(12):1862-7. PubMed ID: 15663560
    [Abstract] [Full Text] [Related]

  • 38. Additional benefit of a third year of specific grass pollen allergoid immunotherapy in patients with seasonal allergic rhinitis.
    Williams A, Henzgen M, Rajakulasingam K.
    Eur Ann Allergy Clin Immunol; 2007 Apr 15; 39(4):123-6. PubMed ID: 17523386
    [Abstract] [Full Text] [Related]

  • 39. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis.
    Casale TB, Busse WW, Kline JN, Ballas ZK, Moss MH, Townley RG, Mokhtarani M, Seyfert-Margolis V, Asare A, Bateman K, Deniz Y, Immune Tolerance Network Group.
    J Allergy Clin Immunol; 2006 Jan 15; 117(1):134-40. PubMed ID: 16387596
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.